Medicare Enrolled
Dr. Naji Kandalaft, M.D.
Cardiovascular Disease · Glendora, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Kandalaft from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Kandalaft?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Kandalaft
Dr. Naji Kandalaft is a cardiovascular disease specialist in Glendora, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Kandalaft performed 12,687 Medicare services across 2,544 unique beneficiaries.
Between the years covered by Open Payments, Dr. Kandalaft received a total of $8,299 from 36 pharmaceutical and/or device companies across 320 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Kandalaft is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 4% volume in CA
$8,299 industry payments
Medicare Practice Summary
Medicare Utilization ↗12,687
Medicare services
Top 4% in CA for cardiovascular disease
2,544
Unique beneficiaries
$33
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~668 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Adenosine injection, 1 mg Administration of a 1 mg dose of adenosine medication. This code is specifically for adenosine and excludes adenosine phosphate compounds. |
8,550 | $0 | $2 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,762 | $99 | $200 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
417 | $67 | $130 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
307 | $12 | $35 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
294 | $176 | $399 |
| Technetium Tc-99m sestamibi diagnostic injection A diagnostic injection of technetium Tc-99m sestamibi used for imaging studies. |
213 | $118 | $276 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram under physician supervision and review. |
179 | $64 | $135 |
| EKG interpretation and report A standard electrocardiogram test that records the heart's electrical activity using at least 12 leads. The service includes a professional interpretation of the results and a written report. |
161 | $7 | $30 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
148 | $121 | $300 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
131 | $140 | $360 |
| Nuclear stress test of heart muscle A nuclear medicine imaging test that evaluates blood flow to the heart muscle at rest and during stress using a special camera. |
108 | $412 | $855 |
| 2-day continuous ECG with review and report A two-day continuous electrocardiogram recording that includes a professional review and written report of the results. |
96 | $59 | $160 |
| Remote pacemaker monitoring, 90 days Remote assessment of a pacemaker system, including single, dual, multiple lead, or leadless devices, performed up to 90 days apart. |
42 | $22 | $55 |
| Remote pacemaker/defibrillator monitoring, 90 days Remote evaluation of a pacemaker or implantable defibrillator system within 90 days of the last check. |
42 | $19 | $50 |
| Transitional care management, high complexity Coordination of care for a patient transitioning from a short-term hospital stay or other facility to home or another care setting. This service addresses a high-complexity medical problem. |
37 | $239 | $425 |
| Ultrasound of head and neck blood flow, bilateral An ultrasound exam that uses sound waves to visualize and assess blood flow in the vessels of both the head and the neck. |
31 | $174 | $388 |
| Sedation by physician, initial 15 minutes Administration of a drug to induce depression of consciousness by the physician performing a procedure. This code covers the initial 15 minutes of sedation for patients aged 5 years or older. |
29 | $10 | $100 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
29 | $111 | $243 |
| Transitional care management services, moderate complexity Services provided to coordinate care during the transition from an inpatient or other facility setting back to the community. This includes follow-up and management of a health problem of at least moderate complexity. |
29 | $181 | $300 |
| Pacemaker programming, dual lead system Adjustment and configuration of a dual-lead pacemaker device to ensure proper operation and settings. |
23 | $67 | $121 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
18 | $100 | $185 |
| Cardiac catheterization | 15 | $225 | $510 |
| Ultrasound of leg arteries or grafts An imaging test that uses sound waves to create pictures of the blood vessels in the legs or any surgical grafts present. |
15 | $228 | $495 |
| Ultrasound of arm or leg veins An ultrasound exam of the veins in the arm or leg. The test uses sound waves to check blood flow and may include compression and other maneuvers. |
11 | $178 | $350 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
3.3% high complexity
71.8% medium
24.9% routine
Industry Payment Transparency
Open Payments through 2024 ↗$8,299
Total received (2018-2024)
Avg $1,186/year across 7 years
Top 31% in CA for cardiovascular disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
36
Companies
320
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$8,299 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,564
2023
$1,423
2022
$918
2021
$1,049
2020
$807
2019
$1,583
2018
$955
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Medtronic, Inc.
$292
Amgen Inc.
$216
CVRx, Inc.
$201
Edwards Lifesciences Corporation
$139
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$126
Esperion Therapeutics, Inc.
$94
Novartis Pharmaceuticals Corporation
$91
Janssen Pharmaceuticals, Inc
$81
Boehringer Ingelheim Pharmaceuticals, Inc.
$74
PFIZER INC.
$49
Novo Nordisk Inc
$42
Lexicon Pharmaceuticals, Inc.
$30
Merck Sharp & Dohme LLC
$26
Kiniksa Pharmaceuticals International, plc
$25
Philips North America LLC
$23
ABIOMED
$20
E.R. Squibb & Sons, L.L.C.
$17
Abbott Laboratories
$15
Top 3 companies account for 45.4% of 2024 payments
All-time payments by company (2018-2024) ›
Medtronic, Inc.
$928
ABIOMED
$871
Amgen Inc.
$682
Novartis Pharmaceuticals Corporation
$677
Janssen Pharmaceuticals, Inc
$601
Abbott Laboratories
$536
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$417
PORTOLA PHARMACEUTICALS, INC.
$326
AstraZeneca Pharmaceuticals LP
$322
PFIZER INC.
$262
La Jolla Pharmaceutical Company
$248
Esperion Therapeutics, Inc.
$237
Merck Sharp & Dohme LLC
$207
CVRx, Inc.
$201
Boehringer Ingelheim Pharmaceuticals, Inc.
$175
BOSTON SCIENTIFIC CORPORATION
$169
Boston Scientific Corporation
$158
BIOTRONIK INC.
$150
Chiesi USA, Inc.
$145
Edwards Lifesciences Corporation
$139
Alexion Pharmaceuticals, Inc.
$125
Amarin Pharma Inc.
$115
E.R. Squibb & Sons, L.L.C.
$108
Gilead Sciences, Inc.
$100
SANOFI-AVENTIS U.S. LLC
$90
Lexicon Pharmaceuticals, Inc.
$54
Novo Nordisk Inc
$42
Regeneron Healthcare Solutions, Inc.
$30
Vertiflex, Inc.
$28
Terumo Medical Corporation
$25
Kiniksa Pharmaceuticals International, plc
$25
Philips Electronics North America Corporation
$25
Philips North America LLC
$23
Medtronic Vascular, Inc.
$23
Merck Sharp & Dohme Corporation
$21
Kowa Pharmaceuticals America, Inc.
$15
Top 3 companies account for 29.9% of all-time payments
Associated products mentioned in payments ›
(BQ9) Coronary IVUS · ANDEXXA · Andexxa · AngioSeal · Arcalyst · BEVYXXA · BRILINTA · Barostim Neo System · Biktarvy · CAMZYOS · CHANTIX · CardioMEMS HF System · CareLink · Confirm Rx · Corlanor · ELIQUIS · ENTRESTO · EUPHORA · Ellipse ICD · FARXIGA · Fortify Assura · GALLANT · GENERAL THERAPIES · GENERAL - THERAPIES · GIAPREZA · Impella · Inpefa · JARDIANCE · KENGREAL · KONECT RESILIA · LATITUDE · LEQVIO · LUX DX · LUX-DX · LifeVest · Livalo · MICRA · MULTAQ · Mitra Clip system · MitraClip System · MyCareLink · NEXLETOL · ONYX FRONTIER · Ozempic · PRADAXA · PRALUENT · Perclose ProGlide suture mediated closure system · RESONATE · Repatha · SYMPLICITY G3 · Superion ISS · Trilogy 100 · VERQUVO · Vascepa · WATCHMAN · XARELTO · XERAVA · XIENCE SKYPOINT · Xience Sierra Coronary Stent System
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Cardiologists within 10 mi
228
Per 100K population
2.3
County median income
$87,760
Nearest hospital
EMANATE HEALTH FOOTHILL PRESBYTERIAN HOSPITAL
3.3 mi
3.3 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Kandalaft is a clinical cardiology specialist, with above-average Medicare volume (top 4% in CA), with low-engagement industry engagement, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Kandalaft experienced with adenosine injection, 1 mg?
Based on Medicare claims data, Dr. Kandalaft performed 8,550 adenosine injection, 1 mg services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Kandalaft receive payments from pharmaceutical companies?
Yes. Dr. Kandalaft received a total of $8,299 from 36 companies across 320 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Kandalaft's costs compare to other cardiologists in Glendora?
Dr. Kandalaft's average Medicare payment per service is $33. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Kandalaft) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiologists in Glendora
Browse cardiologists in Glendora ranked by procedure volume and transparency data.
Highest volume
Top Cardiologists in CA
Cardiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiologists in CA
Which CA cardiologists receive the most from drug and device companies.
By company
Medtronic, Inc. Payments to Doctors
See all physicians who received payments from Medtronic, Inc.
By company
ABIOMED Payments to Doctors
See all physicians who received payments from ABIOMED.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology